The Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver Function

An Evaluation of the Extract of KUAN SIN YIN on Hepatitis C: a Randomized, Double-blinded and Placebo-controlled Clinical Trial.

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01708733

Enrollment

Registered

2012-10-17

Start date

2012-08-31

Completion date

2014-03-31

Last updated

2014-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Function

Keywords

HCV carrier, Chinese herbal medicine, Liver function, HCV RNA titer

Brief summary

The aim of the study is to examine whether the Chinese herbal formula (KSY) is effective on HCV Carrier With Abnormal Liver Function.

Detailed description

percentage of change on HCV RNA titer and liver function (GPT).

Interventions

DRUGKSY

Chinese herbal formula

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* 40 \< GPT \<200 HCV carrier Age: 18-65 yrs old

Exclusion criteria

* Creatinine \>2.0 mg/dL Total bilirubin \> 2.0mg/dL Not suitable patients diagnosis by physician in charge.

Design outcomes

Primary

Measure	Time frame
HCV RNA titer	6 weeks

Secondary

Measure	Time frame
Serum GPT level	6 weeks

Other

Measure	Time frame
WHOQOL-BREF	6 weeks

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026